DA for LMAO and SeaStar Medical

by | Apr 22, 2022

Ending the week with a deal announcement. And the rest of the day’s news in SPACs.

————————————————-
Free Investor Resources from Boardroom Alpha
—————————————————-
** Podcast: Know Who Drives Return
** Daily SPAC Newsletter
** Full SPAC Listing

SPAC Deal: LMAO  + SeaStar Medical

LMF Acquisition Opportunities, Inc.(LMAO) announced a DA with SeaStar Medical, a MedTech company developing extracorporeal therapies to reduce the consequences of excessive inflammation on vital organs. The transaction values SeaStar Medical at an enterprise value of approximately $85 million. Expected completion in the third quarter of 2022.

Spring Valley Acquisition Corp. (SV)/ NuScale Makes Noise Ahead of Next Week’s Vote

Spring Valley Acquisition Corp. (SV) / NuScale Power has a press release ahead of next week’s vote on 4/28. The company announced a partnership with the U.S. Reactor Forging Consortium (RFC) to prepare NuScale to deploy its small modular reactor (SMR) technology to customers.

Deadline Extension: Better World Acquisition Corp. (BWAC)

Better World Acquisition Corp. (BWAC) sets 5/12 for extension vote, an increase of $0.10 per share depending on redemptions for extension to August. Current NAV ~$10.30, up to $10.40 on high redemptions.

Elsewhere in SPACs

  • TradeUP Global Corp. (TUGC). 2M shares redeemed in TUGC / SAITECH (SAI) vote. No specifics on time to close.

Upcoming Merger and Extension Votes

Source: Boardroom Alpha

More from Boardroom Alpha

For ongoing tracking, analytics, and data on SPACs checkout Boardroom Alpha’s SPAC Data and Analytics service.

Recent Analysis

Daily SPAC Update – May 24, 2024

QRDO To Liquidate at $10.96. ShoulderUp Extends with 1.1M Redemptions. BFAC Extension Vote. Churchill Investor Deck. DIST Merger Agreement.

Daily SPAC Update – May 23, 2024

MAQC + Immersed Inc. Deal Terminated. GPAC Deal Vote Set. IVCB Extends w/ 2.1M Redemptions. CVII Investor Deck. PWUP Redemption Agreement.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.